MicroRNA Expression in β-Thalassemia and Sickle Cell Disease: A Role in The Induction of Fetal Hemoglobin

Overview

Journal Cell J

Specialty Cell Biology

Date 2016 Feb 11

PMID 26862517

Citations 21

Authors

Najmaldin Saki

Saeid Abroun

Masoud Soleimani

Maria Kavianpour

Mohammad Shahjahani

Javad Mohammadi-asl

Saeideh Hajizamani

Affiliations

Soon will be listed here.

Abstract

Today the regulatory role of microRNAs (miRs) is well characterized in many diverse cel- lular processes. MiR-based regulation is categorized under epigenetic regulatory mecha- nisms. These small non-coding RNAs participate in producing and maturing erythrocytes, expressing hematopoietic factors and regulating expression of globin genes by post-tran- scriptional gene silencing. The changes in expression of miRs (miR-144/-320/-451/-503) in thalassemic/sickle cells compared with normal erythrocytes may cause clinical severity. According to the suppressive effects of certain miRs (miR-15a/-16-1/-23a/-26b/-27a/-451) on a number of transcription factors [myeloblastosis oncogene (MYB), B-cell lymphoma 11A (BCL11A), GATA1, Krüppel-like factor 3 (KLF3) and specificity protein 1 (Sp1)] during β globin gene expression, It has been possible to increasing γ globin gene expression and fetal hemoglobin (HbF) production. Therefore, this strategy can be used as a novel therapy in infusing HbF and improving clinical complications of patients with hemoglobi- nopathies.

Citing Articles

Potential Use of MicroRNA Technology in Thalassemia Therapy.

Rujito L, Wardana T, Siswandari W, Nainggolan I, Sasongko T J Clin Med Res. 2024; 16(9):411-422.

PMID: 39346566 PMC: 11426174. DOI: 10.14740/jocmr5245.

Spatiotemporal expression and control of haemoglobin in space.

Borg J, Loy C, Kim J, Buhagiar A, Chin C, Damle N Nat Commun. 2024; 15(1):4927.

PMID: 38862545 PMC: 11166948. DOI: 10.1038/s41467-024-49289-8.

Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.

Gambari R, Waziri A, Goonasekera H, Peprah E Int J Mol Sci. 2024; 25(8).

PMID: 38673849 PMC: 11050010. DOI: 10.3390/ijms25084263.

mRNA COVID-19 Vaccines-Facts and Hypotheses on Fragmentation and Encapsulation.

Demongeot J, Fougere C Vaccines (Basel). 2023; 11(1).

PMID: 36679885 PMC: 9864138. DOI: 10.3390/vaccines11010040.

Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets.

Loganathan T, C G Funct Integr Genomics. 2023; 23(1):33.

PMID: 36625940 PMC: 9838419. DOI: 10.1007/s10142-022-00947-4.

References

Pase L, Layton J, Kloosterman W, Carradice D, Waterhouse P, Lieschke G . miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2. Blood. 2008; 113(8):1794-804. PMC: 2647672. DOI: 10.1182/blood-2008-05-155812. View

Mailand N, Falck J, Lukas C, Syljuasen R, Welcker M, Bartek J . Rapid destruction of human Cdc25A in response to DNA damage. Science. 2000; 288(5470):1425-9. DOI: 10.1126/science.288.5470.1425. View

LaMonte G, Philip N, Reardon J, Lacsina J, Majoros W, Chapman L . Translocation of sickle cell erythrocyte microRNAs into Plasmodium falciparum inhibits parasite translation and contributes to malaria resistance. Cell Host Microbe. 2012; 12(2):187-99. PMC: 3442262. DOI: 10.1016/j.chom.2012.06.007. View

Ferreira R, Ohneda K, Yamamoto M, Philipsen S . GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol. 2005; 25(4):1215-27. PMC: 548021. DOI: 10.1128/MCB.25.4.1215-1227.2005. View

Roy P, Bhattacharya G, Lahiri A, Dasgupta U, Banerjee D, Chandra S . hsa-miR-503 is downregulated in β thalassemia major. Acta Haematol. 2012; 128(3):187-9. DOI: 10.1159/000339492. View

Bianchi N, Zuccato C, Lampronti I, Borgatti M, Gambari R . Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression. BMB Rep. 2009; 42(8):493-9. DOI: 10.5483/bmbrep.2009.42.8.493. View

Sarakul O, Vattanaviboon P, Tanaka Y, Fucharoen S, Abe Y, Svasti S . Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210. Blood Cells Mol Dis. 2013; 51(2):98-103. DOI: 10.1016/j.bcmd.2013.03.005. View

Li Y, Bai H, Zhang Z, Li W, Dong L, Wei X . The up-regulation of miR-199b-5p in erythroid differentiation is associated with GATA-1 and NF-E2. Mol Cells. 2014; 37(3):213-9. PMC: 3969041. DOI: 10.14348/molcells.2014.2288. View

Fu Y, Du T, Dong M, Zhu K, Jing C, Zhang Y . Mir-144 selectively regulates embryonic alpha-hemoglobin synthesis during primitive erythropoiesis. Blood. 2008; 113(6):1340-9. DOI: 10.1182/blood-2008-08-174854. View

10.

Sankaran V, Menne T, Scepanovic D, Vergilio J, Ji P, Kim J . MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. Proc Natl Acad Sci U S A. 2011; 108(4):1519-24. PMC: 3029749. DOI: 10.1073/pnas.1018384108. View

11.

Byon J, Papayannopoulou T . MicroRNAs: Allies or foes in erythropoiesis?. J Cell Physiol. 2011; 227(1):7-13. PMC: 3128660. DOI: 10.1002/jcp.22729. View

12.

Roversi F, da Cunha A, Brugnerotto A, Carazzolle M, de Albuquerque D, Lanaro C . Gene expression analysis of the Brazilian type of hereditary persistence of fetal hemoglobin: identification of genes that could be related to γ-globin activation. Hemoglobin. 2013; 37(6):516-35. DOI: 10.3109/03630269.2013.818016. View

13.

Jansson M, Lund A . MicroRNA and cancer. Mol Oncol. 2012; 6(6):590-610. PMC: 5528350. DOI: 10.1016/j.molonc.2012.09.006. View

14.

Noh S, Miller S, Lee Y, Goh S, Marincola F, Stroncek D . Let-7 microRNAs are developmentally regulated in circulating human erythroid cells. J Transl Med. 2009; 7:98. PMC: 2792219. DOI: 10.1186/1479-5876-7-98. View

15.

Ma Y, Wang B, Jiang F, Wang D, Liu H, Yan Y . A feedback loop consisting of microRNA 23a/27a and the β-like globin suppressors KLF3 and SP1 regulates globin gene expression. Mol Cell Biol. 2013; 33(20):3994-4007. PMC: 3811682. DOI: 10.1128/MCB.00623-13. View

16.

Chen S, Wang Y, Telen M, Chi J . The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS One. 2008; 3(6):e2360. PMC: 2408759. DOI: 10.1371/journal.pone.0002360. View

17.

Fathallah H, Taher A, Bazarbachi A, Atweh G . Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease. Blood Cells Mol Dis. 2009; 43(1):58-62. PMC: 2707824. DOI: 10.1016/j.bcmd.2009.02.006. View

18.

Ginder G . Epigenetic regulation of fetal globin gene expression in adult erythroid cells. Transl Res. 2014; 165(1):115-25. PMC: 4227965. DOI: 10.1016/j.trsl.2014.05.002. View

19.

Chan Y, Banerjee J, Choi S, Sen C . miR-210: the master hypoxamir. Microcirculation. 2011; 19(3):215-23. PMC: 3399423. DOI: 10.1111/j.1549-8719.2011.00154.x. View

20.

Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F . MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A. 2005; 102(50):18081-6. PMC: 1312381. DOI: 10.1073/pnas.0506216102. View